Lung Tom W C, Hayes Alison J, Herman William H, Si Lei, Palmer Andrew J, Clarke Philip M
Centre for Health Policy, Programs and Economics, School of Population Health, University of Melbourne, Melbourne, VIC 3053, Australia.
Sydney School of Public Health, Edward Ford Building (A27), The University of Sydney, Sydney, NSW 2006, Australia.
PLoS One. 2014 Nov 26;9(11):e113635. doi: 10.1371/journal.pone.0113635. eCollection 2014.
Type 1 diabetes has been associated with an elevated relative risk (RR) of mortality compared to the general population. To review published studies on the RR of mortality of Type 1 diabetes patients compared to the general population, we conducted a meta-analysis and examined the temporal changes in the RR of mortality over time.
Systematic review of studies reporting RR of mortality for Type 1 diabetes compared to the general population. We conducted meta-analyses using a DerSimonian and Laird random effects model to obtain the average effect and the distribution of RR estimates. Sub-group meta-analyses and multivariate meta-regression analysis was performed to examine heterogeneity. Summary RR with 95% CIs was calculated using a random-effects model.
26 studies with a total of 88 subpopulations were included in the meta-analysis and overall RR of mortality was 3.82 (95% CI 3.41, 3.4.29) compared to the general population. Observations using data prior to 1971 had a much larger estimated RR (5.80 (95% CI 4.20, 8.01)) when compared to: data between; 1971 and 1980 (5.06 (95% CI 3.44, 7.45)); 1981-90 (3.59 (95% CI 3.15, 4.09)); and those after 1990 (3.11 (95% CI 2.47, 3.91)); suggesting mortality of Type 1 diabetes patients when compared to the general population have been improving over time. Similarly, females (4.54 (95% CI 3.79-5.45)) had a larger RR estimate when compared to males (3.25 (95% CI 2.82-3.73) and the meta-regression found evidence for temporal trends and sex (p<0.01) accounting for heterogeneity between studies.
Type 1 diabetes patients' mortality has declined at a faster rate than the general population. However, the largest relative improvements have occurred prior to 1990. Emphasis on intensive blood glucose control alongside blood pressure control and statin therapy may translate into further reductions in mortality in coming years.
与普通人群相比,1型糖尿病患者的相对死亡风险(RR)有所升高。为了回顾已发表的关于1型糖尿病患者与普通人群相比的死亡RR的研究,我们进行了一项荟萃分析,并研究了死亡RR随时间的变化。
系统回顾报告1型糖尿病与普通人群相比的死亡RR的研究。我们使用DerSimonian和Laird随机效应模型进行荟萃分析,以获得平均效应和RR估计值的分布。进行亚组荟萃分析和多变量荟萃回归分析以检查异质性。使用随机效应模型计算95%置信区间的汇总RR。
荟萃分析纳入了26项研究,共88个亚组,与普通人群相比,总体死亡RR为3.82(95%置信区间3.41,3.4.29)。与1971年之前的数据相比,1971年至1980年(5.06(95%置信区间3.44,7.45))、1981 - 1990年(3.59(95%置信区间3.15,4.09))以及1990年之后(3.11(95%置信区间2.47,3.91))的数据,1971年之前数据的估计RR要大得多(5.80(95%置信区间4.20,8.01));这表明与普通人群相比,1型糖尿病患者的死亡率随时间有所改善。同样,女性(4.54(95%置信区间3.79 - 5.45))的RR估计值比男性(3.25(95%置信区间2.82 - 3.73))更大,荟萃回归发现了时间趋势和性别(p<0.01)导致研究间异质性的证据。
1型糖尿病患者的死亡率下降速度比普通人群更快。然而,最大的相对改善发生在1990年之前。强调强化血糖控制以及血压控制和他汀类药物治疗可能会在未来几年进一步降低死亡率。